Diploma (LON:DPLM) Stock Price Expected to Rise, Berenberg Bank Analyst Says

Diploma (LON:DPLM) had its target price upped by stock analysts at Berenberg Bank from GBX 5,750 to GBX 6,350 in a note issued to investors on Wednesday, MarketBeat.com reports. The firm presently has a “buy” rating on the stock. Berenberg Bank’s price objective indicates a potential upside of 14.62% from the company’s current price.

A number of other equities analysts also recently issued reports on DPLM. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a GBX 4,440 price target on shares of Diploma in a research report on Wednesday, August 6th. Jefferies Financial Group boosted their price objective on shares of Diploma from GBX 4,500 to GBX 5,200 and gave the company a “hold” rating in a report on Thursday. Finally, Shore Capital reissued a “hold” rating and set a GBX 5,100 price objective on shares of Diploma in a report on Thursday, July 17th. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of GBX 5,238.

Diploma Stock Performance

Shares of DPLM stock opened at GBX 5,540 on Wednesday. The business’s fifty day simple moving average is GBX 5,273.59 and its 200-day simple moving average is GBX 4,616.20. The company has a market cap of £7.43 billion, a PE ratio of 4,456.96, a PEG ratio of 2.82 and a beta of 0.75. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. Diploma has a 12-month low of GBX 3,532 and a 12-month high of GBX 5,625.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.